Spring til hovednavigation Spring til søgning Spring til hovedindhold

Abstract

Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.

OriginalsprogEngelsk
TidsskriftUgeskrift for Laeger
Vol/bind184
Udgave nummer10
ISSN0041-5782
StatusUdgivet - 7 mar. 2022

Emneord

  • Dyslipidemias/complications
  • Humans
  • Life Style
  • Mental Disorders/complications
  • Prevalence
  • Psychotropic Drugs

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dyslipidaemia in patients with mental illness'. Sammen danner de et unikt fingeraftryk.

Citationsformater